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Non-structural protein 1 (NS1) of the influenza virus plays a crucial role in modulating the host immune response and facili-
tating virus replication. The formation of a homodimer or an oligomer is necessary for NS1 to exert its function efficiently. In 
the present study, the NS1 protein from the A/Shantou/602/06(H3N2) virus (herein abbreviated as NS32) was found to interact 
with NS1 from A/Shantou/169/06(H1N1), A/Chicken/Guangdong/1/05(H5N1) and A/Quail/Hong Kong/G1/97(H9N2) (abbre-
viated as NS11, NS51 and NS92, respectively) viruses, although NS32 shares 17.4%20.9% sequence diversity with NS11, 
NS51 and NS92. This indicates that the heterologous interactions between NS1 proteins from different influenza A virus sub-
types/strains may be a common event during co-infection. 
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The influenza A virus is a common pathogen that causes an 
acute respiratory infection. According to the antigenicity of 
hemagglutinin and neuraminidase, the influenza A virus can 
be divided into numerous subtypes. Currently, at least 16 
HA-subtypes and 9 NA-subtypes have been reported [1]. 
All known subtypes can be found in wild birds, whereas a 
few subtypes are present in some mammalian species, such 
as humans, pigs, horses and seals. 
The RNA genome of the influenza A virus is composed 
of eight segments that encode 11 proteins. The segmented 
genome is favorable for the evolution of the influenza virus 
via a process called reassortment. Reassortment takes place 
in permissive host cells when they are co-infected by at 
least two different influenza viruses. In general, the details 
for co-infection and gene reassortment are far from clear, 
since they are implicated in complex protein-protein and 
protein-RNA interactions between different viruses or be-
tween virus and host cells.  
As a non-structural protein of the influenza virus, 
non-structural protein 1 (NS1) is highly expressed in in-
fected cells. NS1 mainly serves as an antagonist of the host 
immune response or an inhibitor that blocks the processing 
and nuclear export of host mRNA [2]. Two domains, an 
N-terminal RNA-binding domain and a C-terminal effector 
domain, have been identified in the NS1 protein [2]. Both 
the RNA-binding domain [3–6] and the effector domain 
[7,8] have been shown to form dimers individually. More 
importantly, dimerization or oligomerization is crucial for 
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the NS1 protein to interact with RNA [9] and counteract an 
IFN response [10], suggesting the homologous interactions 
between NS1 proteins from the same influenza virus play an 
important role in the infectious process.  
In the present study, we provide evidence for the heter-
ologous interactions between NS1 proteins from different 
influenza A virus subtypes/strains, which have not been 
reported previously. The results contribute to a better un-
derstanding of the complicated biological processes present 
in mixed influenza viruses infections. 
1  Materials and methods 
1.1  Cell lines, viruses and reagents 
The human lung carcinoma cell line (A549) and human 
cervix epithelial cells (Hela) were routinely cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) containing 
antibiotics and 10% fetal calf serum at 37°C in 5% CO2.  
Influenza A virus strains A/Shantou/169/06(H1N1), 
A/Shantou/602/06(H3N2) and A/Chicken/ Guangdong/1/ 
05(H5N1) and viral RNA from the A/Quail/Hong Kong/ 
G1/97(H9N2) strain were used in this study. The viruses 
were abbreviated as ST169, ST602, GD05 and Qa97, re-
spectively. 
Trizol reagent was purchased from Invitrogen (Carlsbad, 
CA, USA), whereas AMV reverse transcriptase, Prime- 
STAR HS DNA polymerase, restriction endonucleases and 
T4 DNA ligase were from TaKaRa (Dalian, China). 
Mouse anti-Flag antibody and peroxidase-conjugated 
goat anti-mouse antibody were from Sigma (St. Louis, MO, 
USA). Rabbit anti-HA antibody was from Cell Signaling 
(Danvers, MA, USA), whereas mouse anti-NS1 antibody 
was from Santa Cruz (Santa Cruz, CA, USA). Mouse an-
ti-HA antibody was from Tiangen (Beijing, China), and 
peroxidase-conjugated goat anti-rabbit antibody and Cy3- 
conjugated goat anti-mouse antibody were from Beyotime 
Biotechnology (Jiangsu, China).  
The yeast MATCHMAKER GAL4 two-hybrid system 3 
and X-α-gal were from Clontech (Palo Alto, CA, USA); the 
MagneGST pull down system, TNT T7 Quick Coupled 
Transcription/Translation Systems and Transcend Chemi-
luminescent Non-Radioactive Translation Detection Sys-
tems were from Promega (Madison, WI, USA); Protein A/G 
magnetic beads were from New England Biolabs (NEB, 
Ipswich, MA, USA); protein G-HRP was from Genescript 
(Piscataway, NJ, USA); and West Dura enhanced chemilu-
minescence reagents were from Pierce (Rockford, IL, 
USA). 
1.2  Plasmids construction 
NS1-encoding sequences from different Influenza A viruses 
(A/Shantou/169/06(H1N1), GenBank: HQ849876; A/ Shan- 
tou/602/06(H3N2), GenBank: HQ849877; A/chicken/ 
Guangdong/1/05(H5N1), GenBank: EU874904; A/Quail/ 
Hong Kong/G1/97(H9N2), GenBank: AF156477) were am-
plified by reverse transcription PCR using viral RNAs and 
the following primer sets: NS11-S1: 5′-AATGGATCCAT- 
GGATTCCCACACTGT-3′ and NS11-A1:5′-TCGGGA- 
TCCTCAAACTTCT GACCTAAT-3′ for A/Shantou/169 
/06(H1N1); NS32-S1: 5′-TATGGATCCATGGATTCC- 
AACACTGTG-3′ and NS32-A1: 5′-TACGGATCCTCAA- 
ACTTTTGACCTAGC-3′ for A/Shantou/602/06(H3N2); 
NS51-S1: 5′-TATGGATCCATGGATTCCAACACTGTG-3′ 
and NS51-A1: 5′-GACGGATCCTCAAACTTTTGACT 
CAATTG-3′ for A/Chicken/Guangdong/1/05(H5N1); and 
NS92-S1: 5′-TATGGATCCATGGATTCCAACACTGTG-3′ 
and NS92-A1: 5′-AGTGGATCCTCAAACTTCTGGCTC- 
AAT-3′ for A/Quail/Hong Kong/G1/97(H9N2). PCR prod-
ucts were digested with BamH I and inserted into the PNF 
vector (a modified pcDNA3 vector with an N-terminal Flag 
tag), pGEX-6p-1 vector, pcDNA3 vector, or pEGFP- C1 
vector, to give the recombinant plasmids Flag- NS11, 
Flag-NS32, Flag-NS51, Flag-NS92, pGEX-NS11, pGEX- 
NS32, pGEX-NS51, pGEX-NS92, pcDNA3-NS32 and 
pEGFP-NS32. NS11, NS32, NS51 and NS92 herein are the 
abbreviations of NS1 proteins from H1N1, H3N2, H5N1 
and H9N2 viruses, respectively.  
To construct NS1-expressing plasmids used for the yeast 
two-hybrid assay, the following primers were designed: 
NS11-S2: 5′-ACTGAATTCATGGATTCCCACACTGTG-3′;  
NS32- S2: 5′-CGTGAATTCATG GATTCCAACACT- 
GTG-3′; NS51-S2: 5′-TATGGATCCTTATGGATTCCAA- 
CACTGTG-3′; and NS92-S2: 5′-CGTGAATTCATGGA- 
TTCCAACACTGTG-3′. The reverse transcription PCR 
reactions were performed using primer sets NS11-S2 and 
NS11-A1 for A/Shantou/169/06(H1N1), NS32-S2 and 
NS32-A1 for A/Shantou/602/06(H3N2), NS51-S2 and 
NS51-A1 for A/Chicken/Guangdong/1/05(H5N1), and 
NS92-S2 and NS92-A1 for A/Quail/Hong Kong/G1/97 
(H9N2). PCR products were digested with appropriate en-
zymes and cloned into either the pGADT7 or pGBKT7 
vector to yield plasmids pGAD-NS11, pGAD-NS32, 
pGAD-NS51, pGAD-NS92 and pGBK-NS32. To generate 
plasmid pcDNA-HA-NS32, the full-length NS1-coding se-
quence of A/Shantou/602/06(H3N2) was amplified using 
primer sets NS32-S1 and NS32-A2 (5′-TACGAATTCTC- 
AAACTTTTGACCTAGC-3′) by reverse transcription PCR 
and fused into pcDNA-HA (a modified pcDNA3 vector 
with an N-terminal HA tag) via BamH I and EcoR I sites. 
All recombinant plasmids were verified by sequencing. 
1.3  Yeast two-hybrid assay 
The yeast two-hybrid assay was performed using the 
MATCHMAKER GAL4 two-hybrid system 3 according to 
the manufacturer’s instruction. Briefly, AH109 yeast was 
transformed with plasmids pGAD-NS11, pGAD-NS32, 
pGAD-NS51 and pGAD-NS92 along with pGBK-NS32 and 
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plated onto the synthetic dropout media SD/-Leu/-Trp 
(DDO) and SD/-Ade/-His/-Leu/-Trp (QDO). AH109 yeasts 
transformed with plasmids pGBKT7-lam plus pGADT7-T 
or pGBKT7-P53 plus pGADT7-T were used as negative 
and positive controls, respectively. The plates were incu-
bated at 30°C for ~4 d. Fresh AH109 colonies growing on 
DDO plates were picked and transferred to QDO plates 
containing X-α-gal (QDO/X-α-gal) followed by incubation 
at 30°C for 2 or 3 d. The growth and color of colonies were 
observed daily.  
1.4  GST pull-down analysis 
Escherichia coli BL21 was transformed with pGEX-6p-1 or 
recombinant plasmids encoding NS1 proteins and grown to 
mid-log phase. IPTG (isopropyl-β-D-thiogalactopyranoside) 
was added to a final concentration of 0.1 mmol L1. The 
cultures were incubated with shaking (200 cycles min1) at 
25°C for 4 h. After 2 cycles of freezing and thawing, bacte-
rial pellets were lysed with the MagneGST lysis reagent 
containing lyticase, DNase and protease inhibitors for 40 
min, followed by centrifugation at 14000×g for 10 min. The 
supernatants were mixed with pre-equilibrated MagneGST 
beads at 4°C for 30 min. The GST-binding or GST-NS1- 
binding beads were washed with binding/wash buffer four 
times and the bound GST or GST-NS1 was separated by a 
12% SDS-PAGE gel and detected by Coomassie blue 
staining. 
In vitro transcription/translation of NS32 was conducted 
using the pcDNA3-NS32 plasmid and TNT T7 Quick Cou-
pled Transcription/Translation Systems, according to the 
protocol of the manufacturer. The expression of the NS32 
protein was examined by Western blot analysis using an 
antibody against NS1.  
GST or GST-NS1 beads were subsequently incubated 
with the NS32 protein at room temperature for 1.5 h. After 
six extensive washing steps with binding/wash buffer, the 
pull-downed proteins were resolved on a 12% SDS-PAGE 
gel and blotted with anti-NS1 antibody. 
1.5  Co-immunoprecipitation (Co-IP) test 
Hela cells were transfected with Flag-tagged NS1-express- 
ing plasmids and a HA-tagged NS32-expressing plasmid, 
individually or in combination. At 36-h post transfection, 
cells were lysed in cold NP-40 lysis buffer on ice for 20 min 
and centrifuged at 14000×g for 10 min. Supernatants were 
pretreated by protein A/G magnetic beads for 1 h. The sam-
ples were then incubated with rabbit anti-HA antibody 
(1:300) at 4°C for 2 h. Normal rabbit IgG was applied to 
serve as a control. Protein-antibody mixtures were further 
incubated overnight with protein A/G magnetic beads at 
4°C with gentle rotation. After extensive washes with the 
NP-40 lysis buffer, the precipitated proteins were run on a 
12% SDS-PAGE gel and probed with the mouse anti-Flag 
antibody (1:800) or mouse anti-HA antibody (1:1000) as 
well as Protein G-HRP (1:2500). In addition, cell lysates 
were directly subjected to SDS-PAGE and Western blotting 
with the indicated antibodies.  
1.6  Immunofluorescence microscopy 
Confluent A549 cells were transfected with the pEGFP- 
NS32 plasmid along with different NS1-expressing plas-
mids or the empty vector PNF. At 24-h post transfection, 
cells were washed with PBS, fixed with 4% paraformalde-
hyde at room temperature for 10 min, permeabilized with 
0.2% Triton X-100 for 10 min, and blocked in PBS con-
taining 3% BSA for 30 min. Subsequently, cells were 
stained with mouse anti-Flag antibody (1:500) diluted in 3% 
BSA-PBS for 2 h. After washing with PBS three times, the 
cells were incubated with Cy3-conjugated goat anti-mouse 
antibody (1:300) for 1 h, followed by 5 min of nu-
clei-staining with Hoechst33258 (1:1000). Finally, digitized 
images were captured by a Zeiss (Axio Imager Z1) fluores-
cent microscope. 
2  Results 
2.1  NS1 proteins from different subtypes vary in their 
amino acid sequences 
Sequence alignment results showed that NS1 proteins from 
four influenza virus subtypes/strains differ in their sequence 
length and amino acids composition. As shown in Figure 1, 
NS1 proteins from influenza viruses A/Shantou/169/ 
06(H1N1), A/Shantou/602/06(H3N2) and A/Quail/Hong 
Kong/G1/97(H9N2) (abbreviated as NS11, NS32 and NS92) 
are 230 residues in length, whereas NS1 from the A/chicken 
/Guangdong/1/05(H5N1) virus (NS51) is only 225 residues 
in length because of a unique five residue deletion between 
position 80 and 84, which is a typical feature of NS1 pro-
teins from H5N1 viruses isolated since 2000 [11,12]. The 
variability in protein sequence between NS32 and NS1 from 
three other viruses (NS11, NS51 and NS92) is 
17.4%–20.9%. In agreement with other reports [13,14] , the 
variation sites mainly distribute in the C-terminal effector 
domain (74–230 aa), in particular, at the very end of the 
C-terminus.  
2.2  Examination of the interactions between NS32 and 
other NS1 proteins using a yeast two-hybrid assay 
To test the possible interactions between NS1 proteins from 
different influenza A virus subtypes/strains, a yeast two- 
hybrid assay was employed. Five recombinant plasmids 
(pGBK-NS32, pGAD-NS11, pGAD-NS32, pGAD-NS51, 
and pGAD-NS92) were constructed, in which NS1 encod-
ing sequences from different influenza A viruses were fused 
to either the DNA-binding domain or the activation domain 
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Figure 1  Schematic diagram depicting the sequence variation among different NS1 proteins. Asterisks above the sequences mark the conserved amino  
acids. Please note that there are five residues missing between positions 80 and 84 of NS1 from the A/chicken/Guangdong/1/05(H5N1) virus. 
of Gal4. These plasmids can be used in the subsequent 
two-hybrid assay, because they do not have auto-activating 
ability when transformed into AH109 yeasts individually 
(data not shown).  
Our results showed that, similar to the positive control 
(pGBKT7-p53 plus pGADT7-T), AH109 yeasts harboring 
each pGADT7-based NS1-expressing plasmid along with 
the pGBK-NS32 plasmid exhibited vigorous growth on the 
QDO plates (Figure 2A) and formed characteristic blue 
colonies on the QDO/X-α-gal plates (Figure 2B), indicating 
the activation of the reporter gene and the secretion of 
α-galactosidase in these yeast cells. In contrast, AH109 
yeast cells in the negative control group (pGBKT7-Lam 
plus pGADT7-T) did not grow on the QDO plates (Figure 
2A), nor did they produce and secrete α-galactosidase on 
the QDO/X-α-gal plate (as shown in Figure 2B, the yeasts 
turned brown and did not survive). These results suggest the 
interactions of NS32 with NS11, NS51 or NS92 in yeast 
cells.  
2.3  In vitro interactions between NS32 and other NS1 
proteins 
We next performed a GST pull-down analysis to detect the 
in vitro interactions between NS32 and other NS1 proteins. 
Four different NS1 proteins with an N-terminal GST tag 
were expressed and immobilized on MagneGST beads (Fig-
ure 3A). The NS32 protein was translated using a cell-free 
system and identified by Western blot (Figure 3B). When 
NS32 was mixed with GST- or GST-NS1-binding beads, it 
can be efficiently pulled down by immobilized GST-NS11, 
GST-NS32, GST-NS51, or GST-NS92 proteins, but cannot 
be precipitated with GST, as revealed in Figure 3C. 
2.4  In vivo interactions between NS32 and other NS1 
proteins 
To further examine whether the NS32 protein can interact 
with NS1 proteins from other influenza A virus sub-
types/strains in mammalian cells, co-IP tests were applied. 
Flag-NS11, Flag-NS51, or Flag-NS92 could easily be de-
tected in protein complexes precipitated by the HA-     
antibody (lane 5 in the upper panels of Figure 4AC) in 
Hela cells co-transfected with plasmids encoding HA-NS32 
and Flag-tagged NS1 proteins. Nevertheless, none of the 
NS1 proteins was precipitated when normal rabbit IgG was 
used (lane 4 in the upper panels of Figure 4AC). Moreover, 
no NS1 protein bands were detected in cells transfected 
with either the HA-NS32 or Flag-NS1 plasmid alone (lanes 
1 and 2 in the upper panels of Figure 4A–C). The above 
phenomena suggest the specific interplay between NS32 
and other NS1 proteins in vivo.  
2.5  Co-localization of NS32 and other NS1 proteins in 
A549 cells 
NS1 is known to be a nuclear protein. When different 
Flag-tagged NS1 proteins were exogenously expressed in 
A549 cells, they predominantly exhibited a diffused distri-
bution with some discrete dots in the nuclei (column 1 in 
Figure 5), as was also observed for the GFP-NS32 fusion 
construct (column 2 in Figure 5). Apparently, overlapping 
localization of most GFP-NS32 protein and Flag-NS11, 
Flag-NS51, or Flag-NS92 were observed in co-transfected 
cells (yellow arrows in Figure 5). Furthermore, although 
GFP-NS32 displayed an almost entirely identical localiza-
tion pattern with the Flag-NS32 protein, a few GFP-NS32  
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Figure 2  Yeast two-hybrid analysis of the interactions between NS32 and other NS1 proteins. A, AH109 yeasts were transformed with pGBK-NS32 plas-
mids together with different pGADT7-based NS1-encoding plasmids and plated on SD/-Ade/-His/-Leu/-Trp (QDO) agar plates for 4 d of incubation at 30°C. 
B, AH109 yeasts transformed with the indicated plasmids were first plated onto SD/-Leu/-Trp (DDO) plates for 4 d of incubation at 30°C. Single AH109 
colonies were then picked and streaked onto QDO/X-α-gal agar plates and incubated at 30°C for 3 d. The representative colonies were presented.  
pGBKT7-p53+pGADT7-T and pGBKT7-Lam+pGADT7-T represented positive and negative controls, respectively. 
 
Figure 3  In vitro binding of NS32 with other NS1 proteins. A, Expression of GST or GST-NS1 proteins in E. coli BL21 and their immobilization on mag-
netic beads. The immobilized GST or GST-NS1 proteins were resolved on SDS-PAGE and examined by direct staining with Coomassie brilliant blue; M, 
molecular weight standards. B, In vitro translation of the NS32 protein using the pcDNA3-NS32 plasmid and TNT T7 Quick Coupled Transcrip-
tion/Translation Systems. The translated NS32 was verified by Western blot analysis using anti-NS1 as the primary antibody. C, Pull-down assay. NS32 was 
incubated with GST, GST-NS11, GST-NS32, GST-NS51, or GST-NS92 immobilized onto magnetic beads. After washing, protein complexes were dissoci- 
ated from the beads and subjected to Western blotting with the anti-NS1 antibody. 
molecules had located to nuclear sites without the distribu-
tion of Flag-NS11, Flag-NS51, or Flag-NS92 (white arrows 
in Figure 5), implying that NS32 cannot efficiently interact 
with these NS1 proteins in these sites within nuclei.  
3  Discussion 
Co-circulation of multiple influenza virus subtypes/strains 
in the same epidemic season and the subsequent mixed in-
fection of an individual by two or more influenza viruses 
provides an opportunity for genetic reassortment. It has 
been established that reassortment is an important evolu-
tionary mechanism for human influenza viruses that has led 
to the emergence of global pandemics of human influenza 
viruses in 1957 (H2N2) [15–17], 1968 (H3N2) [15,16] and 
2009(H1N1) [18].   
Despite annual co-circulation of different influenza virus  
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Figure 4  In vivo association of NS32 with other NS1 proteins. HA-NS32-expressing plasmid and Flag-tagged NS1-expressing plasmids were transfected 
into Hela cells individually or together. After 36 h of transfection, soluble cellular lysates were immunoprecipitated with the rabbit anti-HA antibody or the 
normal rabbit IgG. Precipitated proteins were resolved by 12% SDS-PAGE gels, followed by Western blotting analysis using the mouse anti-Flag antibody  
or the mouse anti-HA antibody. 
subtypes/strains, co-infection of influenza viruses in hu-
mans is believed to be a rare event [19]. The co-infection 
rate determined in one study performed recently in New 
Zealand was 1.1% [20], whereas another study estimated 
this rate to be about 3% [21]. However, the actual rate may 
be under-estimated because current diagnostic methods (e.g., 
multiple PCR) cannot cover all possible infectious combi-
nations of influenza viruses. In addition, compared to hu-
mans, the co-infection rate could be much higher among 
avian species. For example, Dugan and colleagues found 
that up to 26% of the isolates from wild-birds experienced 
mixed infection of different subtypes [22].  
Mixed infection with the pandemic (H1N1) 2009 virus 
and the seasonal (H1N1 or H3N2) influenza viruses, even 
the high pathogenetic H5N1 avian influenza virus has cre-
ated considerable concern, because of the possible genera- 
tion of a virus that can acquire new properties of virulence, 
transmissibility and drug resistance. However, it is note-
worthy that co-infection of an individual by influenza A 
viruses is not a random event; particular virus combinations 
may appear more often or less often than one can expect 
from the rate of single-virus infections [23]. The underlying 
mechanism responsible for this phenomenon remains large-
ly unknown, but it is likely to be correlated with the recip-
rocal influence of different influenza virus strains, which 
means viral components from one virus may facilitate or 
restrict the infectious course of another virus in the same set 
of cells.
 Li W Z, et al.   Sci China Life Sci   June (2012) Vol.55 No.6 513 
 
Figure 5  Immunofluorescence analysis of the localization relationship between NS32 and other NS1 proteins. The GFP-NS32-expressing plasmid was 
transfected into A549 cells in combination with different recombinant plasmids encoding Flag-NS1 (namely Flag-NS11, Flag-NS32, Flag-NS51, or 
Flag-NS92) or empty vector PNF (a modified pcDNA3 vector with an N-terminal Flag tag). At 24-h post transfection, cells were immunostained with the 
mouse anti-Flag antibody and the Cy3-labeled goat anti-mouse secondary antibody. Nuclei were counterstained with Hoechst 33258. Localization of the 
Flag-NS1 protein (red), GFP-NS32 (green), overlaid images of Flag-NS1 proteins and GFP-NS32 (yellow), and nuclei (blue) are shown. Yellow and white  
arrows indicate the same and different localization patterns, respectively, of the GFP-NS32 protein with Flag-NS11, Flag-NS51, or Flag-NS92. 
In our study, a series of experiments (yeast two-hybrid 
assay, GST pull-down, co-immunoprecipitation, and im-
munofluorescence analysis) were performed to examine the 
interactions between NS1 proteins from different influenza 
A virus subtypes/strains. Here, NS1 proteins from four dif-
ferent influenza A virus subtypes (NS11, NS32, NS51 and 
NS92) were used and we selected NS1 from the A/Shantou/ 
602/06(H3N2) virus as the major subject. This is because 
NS1 proteins from many H3N2 viruses can locate to the 
nucleoli of mammalian cells, which has not been observed 
for most NS1 proteins from other influenza virus subtypes 
[24–26]. In our previous study, we also noticed a distinct 
distribution pattern of NS32 in Hela cells with NS11, NS51 
and NS92 [27]. The unique nucleolus localization of NS32 
protein may modulate the synthesis of host rRNA and hence 
affect the pathogenicity of the influenza virus [26,28]. Fur-
thermore, we found that the NS32 protein exhibited re-
markable variation in the transcription-stimulating capabil-
ity in yeast when compared to NS11, NS51 and NS92 [29]. 
In the present study, we further show that NS32 is able to 
efficiently interact with NS11, NS51 and NS92 both in vitro 
and in vivo, albeit harboring 17.4%–20.9% sequence diver-
sity compared with the other three NS1 proteins (Figure 1). 
This is the first report regarding heterologous interactions 
between different NS1 proteins.  
Results from a previous study indicated that NS1 func-
tions as a homodimer or multimer in vivo [30]. A more re-
cent study further described a unique tubular structure based 
on the homologous NS1 multimer [31]. This structure con-
fers extreme flexibility to NS1 and enables NS1 to bind 
different lengths of dsRNA [31]. Apart from its RNA- 
binding activity, NS1 can also interact with a number of 
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cellular proteins to facilitate the replication of the influenza 
virus. The average length of NS1 is 230 residues. However, 
the variations of NS1 in amino acids sequence such as trun-
cation, deletion, insertion or residue substitutions are popu-
lar among all subtypes of the influenza A virus [14]. The 
variations sometimes cause an alternation in the function of 
NS1. For example, F103S and M106I mutations in NS1 
abrogated its ability to bind CPSF30 (cleavage and polyad-
enylation specificity factor 30 kD) [32]. Additionally, be-
cause of sequence variation, NS1 from different influenza 
viruses exerts differential inhibitory effects on RNAi [33]. 
Although NS32 used in this study shares about 82.6%, 
79.6% and 79.1% identity with NS11, NS51 and NS92, 
respectively (Figure 1), these NS1 proteins differ in their 
transcription-activating ability in yeast cells [29] and 
PI3K-activating ability in mammalian cells [34]. Accord-
ingly, we cannot exclude the possibility that the heterolo-
gous interactions between different NS1 proteins may affect 
the formation of highly ordered spatial structures and/or the 
biological function of the NS1 dimer or multimer. However, 
our attempt to explore the functional significance of the 
heterologous NS1 interactions was hampered by the fact 
that the biological effects induced by the simultaneous ex-
pression of two different NS1 proteins in one cell may result 
from the competitive binding of different NS1 proteins with 
the same host factor but not NS1-NS1 interactions.  
In summary, heterologous interactions between different 
NS1 proteins during co-infection appear to be a common 
phenomenon, but its role on the severity and outcome of 
co-infection awaits clarification. 
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